Annual ROE
61.68%
+144.34%+174.62%
30 June 2024
Summary:
MEI Pharma annual return on equity is currently 61.68%, with the most recent change of +144.34% (+174.62%) on 30 June 2024. During the last 3 years, it has risen by +126.98% (+194.46%). MEIP annual ROE is now at all-time high.MEIP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-110.69%
-142.31%-450.06%
30 September 2024
Summary:
MEI Pharma quarterly return on equity is currently -110.69%, with the most recent change of -142.31% (-450.06%) on 30 September 2024. Over the past year, it has dropped by -201.74% (-221.57%). MEIP quarterly ROE is now -221.57% below its all-time high of 91.05%, reached on 30 September 2023.MEIP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MEIP ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +174.6% | -221.6% |
| 3 y3 years | +194.5% | -4.9% |
| 5 y5 years | +280.4% | -850.1% |
MEIP ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +157.7% | -221.6% | +3.7% |
| 5 y | 5 years | at high | +157.7% | -221.6% | +3.7% |
| alltime | all time | at high | +126.2% | -221.6% | +56.6% |
MEI Pharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -110.69%(-450.1%) |
| June 2024 | 61.68%(-174.6%) | 31.62%(-34.6%) |
| Mar 2024 | - | 48.32%(+21.7%) |
| Dec 2023 | - | 39.72%(-56.4%) |
| Sept 2023 | - | 91.05%(-212.7%) |
| June 2023 | -82.66%(-22.7%) | -80.78%(+2.5%) |
| Mar 2023 | - | -78.82%(+43.3%) |
| Dec 2022 | - | -55.02%(-45.2%) |
| Sept 2022 | - | -100.46%(+2.9%) |
| June 2022 | -106.90%(+63.7%) | -97.67%(+13.3%) |
| Mar 2022 | - | -86.19%(-25.0%) |
| Dec 2021 | - | -114.92%(+8.9%) |
| Sept 2021 | - | -105.53%(+67.2%) |
| June 2021 | -65.30%(-13.5%) | -63.11%(-15.4%) |
| Mar 2021 | - | -74.60%(+83.5%) |
| Dec 2020 | - | -40.65%(-33.0%) |
| Sept 2020 | - | -60.63%(-16.7%) |
| June 2020 | -75.48%(+120.8%) | -72.79%(+69.4%) |
| Mar 2020 | - | -42.98%(-39.5%) |
| Dec 2019 | - | -71.09%(+510.2%) |
| Sept 2019 | - | -11.65%(-68.2%) |
| June 2019 | -34.19%(-56.8%) | -36.64%(-59.8%) |
| Mar 2019 | - | -91.21%(+41.5%) |
| Dec 2018 | - | -64.47%(-42.3%) |
| Sept 2018 | - | -111.73%(+20.5%) |
| June 2018 | -79.11%(-1471.1%) | -92.69%(+62.5%) |
| Mar 2018 | - | -57.03%(+39.6%) |
| Dec 2017 | - | -40.84%(+989.1%) |
| Sept 2017 | - | -3.75%(-168.7%) |
| June 2017 | 5.77%(-114.0%) | 5.46%(+111.6%) |
| Mar 2017 | - | 2.58%(-134.7%) |
| Dec 2016 | - | -7.43%(-82.7%) |
| Sept 2016 | - | -43.01%(+5.5%) |
| June 2016 | -41.13%(-34.0%) | -40.76%(+9.7%) |
| Mar 2016 | - | -37.16%(-6.7%) |
| Dec 2015 | - | -39.83%(-18.1%) |
| Sept 2015 | - | -48.64%(-16.6%) |
| June 2015 | -62.28%(-8.2%) | -58.30%(-10.5%) |
| Mar 2015 | - | -65.12%(+2.1%) |
| Dec 2014 | - | -63.75%(-8.1%) |
| Sept 2014 | - | -69.37%(+13.7%) |
| June 2014 | -67.82% | -61.02%(+12.1%) |
| Mar 2014 | - | -54.44%(+10.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | - | -49.48%(-14.5%) |
| Sept 2013 | - | -57.85%(-5.7%) |
| June 2013 | -56.68%(-75.9%) | -61.36%(-29.2%) |
| Mar 2013 | - | -86.72%(-29.8%) |
| Dec 2012 | - | -123.46%(-51.7%) |
| Sept 2012 | - | -255.35%(+5.0%) |
| June 2012 | -235.35%(+59.2%) | -243.18%(-2.1%) |
| Mar 2012 | - | -248.47%(+32.0%) |
| Dec 2011 | - | -188.22%(+2.4%) |
| Sept 2011 | - | -183.88%(+19.7%) |
| June 2011 | -147.81%(+111.5%) | -153.66%(+29.6%) |
| Mar 2011 | - | -118.60%(+12.7%) |
| Dec 2010 | - | -105.22%(+34.9%) |
| Sept 2010 | - | -77.99%(+10.5%) |
| June 2010 | -69.89%(-0.8%) | -70.59%(-14.9%) |
| Mar 2010 | - | -82.96%(+22.6%) |
| Dec 2009 | - | -67.66%(+13.8%) |
| Sept 2009 | - | -59.45%(+5.4%) |
| June 2009 | -70.43%(-14.0%) | -56.43%(+27.9%) |
| Mar 2009 | - | -44.11%(-11.3%) |
| Dec 2008 | - | -49.73%(-3.6%) |
| Sept 2008 | - | -51.59%(-17.6%) |
| June 2008 | -81.88%(-32.1%) | -62.61%(+11.5%) |
| Mar 2008 | - | -56.16%(+14.2%) |
| Dec 2007 | - | -49.16%(-2.2%) |
| Sept 2007 | - | -50.29%(-44.6%) |
| June 2007 | -120.64%(+109.5%) | -90.83%(+6.1%) |
| Mar 2007 | - | -85.64%(-14.6%) |
| Dec 2006 | - | -100.27%(-1.3%) |
| Sept 2006 | - | -101.62%(+73.4%) |
| June 2006 | -57.58%(+77.0%) | -58.62%(-4.6%) |
| Mar 2006 | - | -61.47%(+38.1%) |
| Dec 2005 | - | -44.50%(+16.9%) |
| Sept 2005 | - | -38.06%(+18.7%) |
| June 2005 | -32.54%(-45.0%) | -32.07%(+24.6%) |
| Mar 2005 | - | -25.74%(+10.5%) |
| Dec 2004 | - | -23.29%(-46.5%) |
| Sept 2004 | - | -43.57%(-14.8%) |
| June 2004 | -59.14%(+44.6%) | -51.11%(-9.2%) |
| Mar 2004 | - | -56.28%(-9.8%) |
| Dec 2003 | - | -62.40%(+16.0%) |
| Sept 2003 | - | -53.81%(+78.9%) |
| June 2003 | -40.90%(+2863.8%) | -30.07% |
| June 2002 | -1.38% | - |
FAQ
- What is MEI Pharma annual return on equity?
- What is the all time high annual ROE for MEI Pharma?
- What is MEI Pharma annual ROE year-on-year change?
- What is MEI Pharma quarterly return on equity?
- What is the all time high quarterly ROE for MEI Pharma?
- What is MEI Pharma quarterly ROE year-on-year change?
What is MEI Pharma annual return on equity?
The current annual ROE of MEIP is 61.68%
What is the all time high annual ROE for MEI Pharma?
MEI Pharma all-time high annual return on equity is 61.68%
What is MEI Pharma annual ROE year-on-year change?
Over the past year, MEIP annual return on equity has changed by +144.34% (+174.62%)
What is MEI Pharma quarterly return on equity?
The current quarterly ROE of MEIP is -110.69%
What is the all time high quarterly ROE for MEI Pharma?
MEI Pharma all-time high quarterly return on equity is 91.05%
What is MEI Pharma quarterly ROE year-on-year change?
Over the past year, MEIP quarterly return on equity has changed by -201.74% (-221.57%)